Literature DB >> 9690841

Well-being of haemophilia patients: a model for direct and indirect effects of medical parameters on the physical and psychosocial functioning.

A H Triemstra1, H M Van der Ploeg, C Smit, E Briët, H J Adèr, F R Rosendaal.   

Abstract

This study outlines the development and evaluation of a structural equation model for establishing the consequences of haemophilia. The hereditary disorder is characterized by a high tendency to haemorrhages, with recurrent bleeding into the joints causing irreversible joint damage. The model is, in general, an attempt to answer the following questions: what is the effect of haemophilia on the well-being (i.e. satisfaction, health, somatic complaints and self-esteem) of patients and what is the additional or mediating role of other individual characteristics in this pathway? Disease severity, joint impairment and disability are defined as antecedents of well-being and the mediating roles of appraisal (i.e. the personal evaluation of the disease), health beliefs (i.e. locus of control), psychological characteristics (i.e. anxiety, anger, depression and optimism) and social support are investigated. Psychological variables turned out to be the strongest determinants of well-being and partly mediated the detrimental effect of disability on well-being. The role of appraisal remained somewhat unclear, as no significant relationship was established between this personal evaluation of haemophilia and well-being. Nevertheless, appraisal very well reflected the level of disability. An internal locus of control and favourable psychological characteristics appeared to reduce the perceived seriousness of haemophilia. No evidence was found for social support to act as a mediator between disability and well-being. The perception of support did show moderately strong associations with psychological characteristics (i.e. anxiety and depression) and satisfaction ratings. The study merits further research on quantifying the relationships between clinical parameters and psychosocial outcomes in patients with a chronic disease.

Entities:  

Mesh:

Year:  1998        PMID: 9690841     DOI: 10.1016/s0277-9536(98)00117-8

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

Review 1.  Psychosocial Adaptation to Disability Within the Context of Positive Psychology: Findings from the Literature.

Authors:  Erin Martz; Hanoch Livneh
Journal:  J Occup Rehabil       Date:  2016-03

2.  The mediating role of optimism on post-radiation quality of life in nasopharyngeal carcinoma.

Authors:  Clara L M Yu; Richard Fielding; Cecilia L W Chan
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

3.  Quality of life and pain in Chinese lung cancer patients: Is optimism a moderator or mediator?

Authors:  Wing S Wong; R Fielding
Journal:  Qual Life Res       Date:  2006-11-08       Impact factor: 4.147

4.  Assessing quality of life in individuals with hereditary blood coagulation disorders.

Authors:  S Solovieva; N Santavirta; S Santavirta; Y T Konttinen
Journal:  Qual Life Res       Date:  2004-06       Impact factor: 4.147

5.  Development and psychometric testing of the Hemophilia Well-being Index.

Authors:  Eduardo Remor
Journal:  Int J Behav Med       Date:  2013-12

6.  Assessment of healthcare measures, healthcare resource use, and cost of care among severe hemophilia A patients in Mumbai region of India.

Authors:  U Jadhav; K Mukherjee
Journal:  J Postgrad Med       Date:  2018 Jul-Sep       Impact factor: 1.476

7.  Health care professionals dealing with hemophilia: insights from the international qualitative study of the HERO initiative.

Authors:  Silvia Potì; Laura Palareti; Frederica Rmy Cassis; Sonia Brondi
Journal:  J Multidiscip Healthc       Date:  2019-05-09

Review 8.  Measuring therapeutic relationship in the care of patients with haemophilia: A scoping review.

Authors:  Erin McCabe; Maxi Miciak; Liz Dennett; Patricia Manns; Christine Guptill; Jeremy Hall; Douglas P Gross
Journal:  Health Expect       Date:  2018-08-29       Impact factor: 3.377

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.